Immediate Impact
1 from Science/Nature 50 standout
Citing Papers
Colorectal cancer
2024 Standout
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial
2024 Standout
Works of Chihiro Kosugi being referenced
Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study
2020
VOICE trial: Final results from multicenter phaseII study of assessment of clinical efficiency and safety in capecitabine plus intermittent oxaliplatin together with bevacizumab as first-line therapy for patients with advanced colorectal cancer.
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Chihiro Kosugi | 660 | 684 | 284 | 85 | 1.2k | |
| Nalân Akyürek | 423 | 284 | 393 | 124 | 1.7k | |
| Sundeep Singh Saluja | 357 | 1001 | 580 | 97 | 1.4k | |
| Shunichiro Komatsu | 319 | 594 | 288 | 101 | 1.4k | |
| H. Štern | 691 | 446 | 140 | 39 | 1.3k | |
| Chieko Hamada | 301 | 522 | 301 | 107 | 1.6k | |
| Seong Taek Oh | 687 | 727 | 213 | 92 | 1.6k | |
| Sun‐Young Jun | 455 | 390 | 557 | 99 | 1.6k | |
| Masakatsu Yamamoto | 228 | 333 | 147 | 59 | 1.0k | |
| Ferit Avcu | 213 | 365 | 151 | 85 | 1.4k | |
| Shingo Tsujinaka | 599 | 520 | 244 | 74 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...